Doctor explains what FDA'a approval of pancreatic cancer drug could mean for patients

Doctor explains what FDA'a approval of pancreatic cancer drug could mean for patients‎

CBS

02:55

The FDA has approved a drug that could extend the life of patients with late-stage pancreatic cancer. CBS News' medical correspondent Dr. Céline Gounder has more.

המשך קריאה ב 'CBS'

כתבה אחת דומה

FDA approves new pancreatic cancer drug that could extend patients' lives‎

Patients taking the first-of-a-kind pill, called daraxonrasib, lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients, studies showed.

CBS

02:02, עידכון: 03:36

תפריט כתבה

דיווח על כתבה זו הסתרת כתבות מאתר זה המשך קריאה באתר המקור